Introduction: Incidence of oral epithelial dysplasia and oral squamous cell carcinoma (SCC) is very high in south Asian countries as compared to western population owing to a greater use of tobacco in these regions. While visual examination and exfoliative cytology are the most common screening and diagnostic modalities at present, it is a subjective analysis. Quantitative analyses such as nuclear size, cell size, and nuclear-to-cytoplasmic ratio may provide an accurate diagnosis and improve reproducibility. The aim of the study was to evaluate the role of morphometry as a diagnostic adjunct to exfoliative cytology and to derive a significant cutoff to identify the population at risk for development of SCC among chronic tobacco users. Material and Methods: This was an outpatient-based prospective study done in a tertiary hospital over a period of 2 years. Hundred and fifty cases with a history of chronic tobacco use for a minimum period of 5 years were evaluated. Visual inspection using acetic acid was done. Oral scrapes were taken for cytological and morphometric analysis followed by incision biopsy for histopathological evaluation, wherever possible. Results: On morphometrical analysis, mean nuclear area and nuclear:cytoplasmic (N:C) ratio increased, while the cytoplasmic area decreased from smears with normal cytology to oral dysplasia to SCC. Analysis of variance and post hoc Tukey’s honest significant difference test showed a statistically significant difference among the 3 groups (p value <0.05). A cutoff value for a significant N:C ratio was calculated as ≥0.08 using Youden’s index with a sensitivity and a specificity of 88% and 94%, respectively. Conclusion: In high-risk cases, morphometry can be a useful adjunct to exfoliative cytology and visual examination for an early and accurate diagnosis and timely intervention in oral potentially malignant and malignant lesions, thereby improving the prognosis.

1.
Brocklehurst
P
,
Kujan
O
,
O’Malley
LA
,
Ogden
G
,
Shepherd
S
,
Glenny
AM
.
Screening programmes for the early detection and prevention of oral cancer
.
Cochrane Database Syst Rev
.
2013
;
11
:
CD004150
. .
2.
GLOBOCAN
.
Estimated cancer incidence, mortality and prevalence worldwide in 2012
.
International Agency for Research on Cancer
;
2012
.
3.
Varshitha
A
.
Prevalence of oral cancer in India
.
J Pharm Sci Res
.
2015
;
7
:
845
.
4.
Saran
S
,
Agrawal
GN
.
Cancer pattern in Central U.P
.
Indian J Cancer
.
1984
;
21
:
133
6
.
5.
Johnson
NW
,
Amarasinghe
HK
.
Epidemiology and aetiology of head and neck cancers
. In:
Benier
J
, editor.
Head and neck cancer: multimodality management
.
London
:
Springer
;
2011
. p.
1
40
. .
6.
Palakurthy
P
,
Kulkarni
PG
,
Nandan
RK
,
Rao
TM
,
Reddy
DSP
,
Muddana
K
.
Cytological changes in normal oral mucosa of individuals with tobacco habits: a cytomorphometric study
.
J Contemp Dent Pract
.
2017
;
18
(
8
):
722
7
. .
7.
Mohanta
A
,
Mohanty
PK
.
Cytomorphometric analysis of non-keratinized malignant squamous cells in exfoliated cytosmears of human oral neoplasm
.
J Carcinog Mutagene
.
2016
;
7
:
247
.
8.
Afrogheh
A
,
Wright
CA
,
Sellars
SL
,
Wetter
J
,
Pelser
A
,
Schubert
PT
,
An evaluation of the Shandon Papspin liquid-based oral test using a novel cytologic scoring system
.
Oral Surg Oral Med Oral Pathol Oral Radiol
.
2012 Jun
;
113
(
6
):
799
807
. .
9.
Mehrotra
R
,
Singh
M
,
Gupta
RK
,
Singh
M
,
Kapoor
AK
.
Trends of prevalence and pathological spectrum of head and neck cancers in North India
.
Indian J Cancer
.
2005
;
42
:
89
93
. .
10.
EI-Naggar
AK
,
Chan
JKCG
,
Randis
JR
,
Takata
T
,
Slootweg
PJ
, editors.
WHO Classification of head and neck tumours
. 4th ed.
Lyon
:
IARC
;
2017
.
11.
Alsarraf
A
,
Kujan
O
,
Farah
CS
.
The utility of oral brush cytology in the early detection of oral cancer and oral potentially malignant disorders: a systematic review
.
J Oral Pathol Med
.
2017
;
47
(
2
):
104
16
.
12.
Diniz-Freitas
M
,
García-García
A
,
Crespo-Abelleira
A
,
Martins-Carneiro
JL
,
Gándara-Rey
JM
.
Applications of exfoliative cytology in the diagnosis of oral cancer
.
Med Oral
.
2004
;
9
:
355
61
.
13.
Cowpe
JG
,
Longmore
RB
,
Green
MW
.
Quantitative exfoliative cytology of normal oral squames: an age, site and sex related survey
.
J R Soc Med
.
1985
;
78
:
995
1004
.
14.
Frost
JK
.
Pathologic processes affecting cells from inflammation to cancer
. In:
BIBBO
M
, editor.
Comprehensive cytopathology
. 2nd ed.
Philadelphia
:
W.B. Saunders Company
;
1997
. p.
68
78
.
15.
Maraki
D
,
Becker
J
,
Boecking
A
.
Cytologic and DNA-cytometric very early diagnosis of oral cancer
.
J Oral Pathol Med
.
2004
;
33
:
398
404
. .
16.
Camilleri
GE
,
Smith
CJ
.
Exfoliative cytology of the early lesions of experimental oral cancer in the hamster
.
Arch Oral Biol
.
1965
;
10
:
465
70
. .
17.
Kuyama
K
,
Matsumoto
T
,
Morikawa
M
,
Fukatsu
A
,
Ichimura
M
,
Wakami
M
,
Morphometrical findings among dysplasias of oral, cervical and bronchial regions
.
Open J Stomatol
.
2013
;
03
(
02
):
215
22
. .
18.
Hande
AH
,
Chaudhary
MS
.
Cytomorphometric analysis of buccal mucosa of tobacco chewers
.
Rom J Morphol Embryol
.
2010
;
51
(
3
):
527
32
.
19.
Joshi
P
,
Kaijkar
M
.
Cytomorphometric analysis of oral premalignant and malignant lesions using Feulgen stain and exfoliative brush cytology
.
J Interdiscipl Histopathol
.
2013
;
1
(
4
):
204
11
. .
20.
Nivia
M
,
Sunil
SN
,
Rathy
R
,
Anilkumar
TV
.
Comparative cytomorphometric analysis of oral mucosal cells in normal, tobacco users, oral leukoplakia and oral squamous cell carcinoma
.
J Cytol
.
2015
;
32
(
4
):
253
60
. .
21.
Verma
R
,
Singh
A
,
Badni
M
,
Chandra
A
,
Gupta
S
,
Verma
R
.
Evaluation of exfoliative cytology in the diagnosis of oral premalignant and malignant lesions: a cytomorphometric analysis
.
Dent Res J
.
2015
;
12
(
1
):
83
8
. .
22.
Buch
A
,
Patel
SS
,
Chandanwale
SS
,
Kumar
H
,
Patel
KM
,
Bamanikar
SA
.
Study of oral exfoliative cytology in tobacco chewers of western India
.
IJPBS
.
2014
;
4
(
1
):
138
43
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.